Ctrl

K

Table of contents

Expand All Topics

Primary ovarian insufficiency

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of primary ovarian insufficiency are prepared by our editorial team based on guidelines from the American Society for Reproductive Medicine (ASRM/ESHRE 2024), the American College of Obstetricians and Gynecologists (ACOG 2017), the European Society of Human Reproduction and Embryology (ESHRE 2016), and the Endocrine Society (ES 2015).
1
2
3
4

Screening and diagnosis

Definition: as per ASRM/ESHRE 2024 guidelines, use the term ‘premature ovarian insufficiency' to describe this condition in research and clinical practice.
B
Show 2 more
Create free account

More topics in this section

  • Indications for testing (symptomatic patients)

  • Indications for testing (family relatives)

  • Diagnostic criteria

Classification and risk stratification

Health risks
As per ASRM/ESHRE 2024 guidelines:
Make efforts to reduce the risk of POI, in view of the long-term health consequences of POI, including the following modifiable factors:
gynecological surgical practice
lifestyle factors such as smoking
treatment regimens for malignant and chronic diseases
B
Identify females with risk factors for POI and counsel regarding POI risk and fertility preservation.
B

Diagnostic investigations

Medical history: as per ASRM/ESHRE 2024 guidelines, enquire about symptoms of estrogen deficiency in patients presenting with irregular menstrual cycles or amenorrhea.
B

More topics in this section

  • Cardiovascular evaluation

  • Screening for diabetes

  • Screening for infection

  • Bone mineral density testing

  • Hormone testing (FSH)

  • Hormone testing (estradiol)

  • Hormone testing (anti-Müllerian hormone)

  • Karyotyping

  • Genetic testing

  • Screening for adrenocortical antibodies

  • Screening for thyroid antibodies

Medical management

Hormone therapy: as per ACOG 2017 guidelines, initiate systemic hormone therapy, if not contraindicated, to treat hypoestrogenism symptoms and mitigate long-term health risks in patients with POI.
E
Show 3 more

More topics in this section

  • Duration of treatment

  • Contraception

  • Fertility preservation

  • Evaluation for pregnancy

  • Management of pregnancy

  • Bone protection

  • Muscle protection

Nonpharmacologic interventions

Lifestyle modifications: as per ASRM/ESHRE 2024 guidelines, encourage patients with POI to adopt a healthy lifestyle (including avoiding smoking, having a healthy diet and regular physical activity, and maintaining a healthy weight range) to reduce cardiovascular risk.
B

Patient education

General counseling: as per ASRM/ESHRE 2024 guidelines, convey the diagnosis of POI in a compassionate and sensitive manner, provide personalized evidence-based information about the condition and ensure time for the patients to ask questions.
B
Show 6 more

More topics in this section

  • Pre-pregnancy counseling